100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
78995-75-2Adrenaline EP Impurity F
● In Stock
| Catalogue No.: | VL3990006 |
|---|---|
| CAS No.: | 78995-75-2 |
| Mol. Formula: | C9H13NO5S |
| Mol. Weight: | 247.27 g/mol |
Additional information on CAS 78995-75-2
Parent drug
Adrenaline / EpinephrineIUPAC Name
(1R)-1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethane-1-sulfonic acidPharmacopeial Synonyms
Epinephrine SulfonateOther Synonyms
Epinephrine Impurity FSmiles
OC1=C(C=CC([C@@](S(=O)(O)=O)(CNC)[H])=C1)OInChI
InChI=1S/C9H13NO5S/c1-10-5-9(16(13,14)15)6-2-3-7(11)8(12)4-6/h2-4,9-12H,5H2,1H3,(H,13,14,15)/t9-/m0/s1Description
Adrenaline EP Impurity F, also known as Epinephrine Sulfonate in various pharmacopoeias, is a highly characterized standard. It meets strict regulatory requirements set by USP, EMA, JP, and BP, making it a crucial component in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Adrenaline/ Epinephrine. Epinephrine is a choice of drug in systemic anaphylaxis.
References
Doğan, Semih, et al. “Dibenzylamine Substituted Cyclotetraphosphazenes: Synthesis, Characterization and Their Stereogenic Properties.†Inorganica Chimica Acta, vol. 482, Oct. 2018, pp. 144–53, https://doi.org/10.1016/j.ica.2018.06.014. “Synthesis and Characterization of Side Group–Modified Cyclotetraphosphazene Derivatives.†Phosphorus, Sulfur, and Silicon, 2011, www.tandfonline.com/doi/abs/10.1080/10426507.2010.496120. ‌ ‌Request a Quote
"*" indicates required fields
Other products related to Adrenaline and Epinephrine impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
